Acute kidney injury: novel biomarkers and potential utility for patient care in urology.
Urologists are integrally involved in the management of acute kidney injury (AKI), which is common after renal surgery or secondary to postrenal (obstructive) etiologies. The measurement of serum creatinine is a suboptimal indicator of AKI because it lags behind acute changes in renal function. Recent advances indicate that serum/urine biomarkers will prove useful for early detection of AKI, analogous to the use of cardiac enzymes for acute myocardial infarction. These serum/urine markers may guide future therapy, facilitate research efforts to reduce the severity of AKI, such as after partial nephrectomy, and allow for more accurate prognostication for patients with AKI.
Thomas
Anil A
AA
Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Demirjian
Sevag
S
Lane
Brian R
BR
Simmons
Matthew N
MN
Goldfarb
David A
DA
Subramanian
Vairavan S
VS
Campbell
Steven C
SC
D058186:Acute Kidney Injury / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D015415:Biomarkers / Q000032:analysis; D006801:Humans; D009392:Nephrectomy / Q000009:adverse effects / Q000379:methods; D014572:Urology
D015415:Biomarkers